Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Use of Radical Cystectomy for Patients With Invasive Bladder Cancer
John L. Gore, Mark S. Litwin, Joon-Keat Lai, et al.
JNCI Journal of the National Cancer Institute (2010) Vol. 102, Iss. 11, pp. 802-811
Open Access | Times Cited: 273

Showing 1-25 of 273 citing articles:

Treatment of muscle‐invasive and advanced bladder cancer in 2020
Vaibhav G. Patel, William Oh, Matthew D. Galsky
CA A Cancer Journal for Clinicians (2020) Vol. 70, Iss. 5, pp. 404-423
Open Access | Times Cited: 804
Critical Analysis of Bladder Sparing with Trimodal Therapy in Muscle-invasive Bladder Cancer: A Systematic Review
Guillaume Ploussard, Siamak Daneshmand, Jason A. Efstathiou, et al.
European Urology (2014) Vol. 66, Iss. 1, pp. 120-137
Closed Access | Times Cited: 328
Propensity Score Analysis of Radical Cystectomy Versus Bladder-Sparing Trimodal Therapy in the Setting of a Multidisciplinary Bladder Cancer Clinic
Girish S. Kulkarni, Thomas Hermanns, Yanliang Wei, et al.
Journal of Clinical Oncology (2017) Vol. 35, Iss. 20, pp. 2299-2305
Open Access | Times Cited: 274
Incidence, survival and mortality rates of stage-specific bladder cancer in United States: A trend analysis
Firas Abdollah, Giorgio Gandaglia, Rodolphe Thuret, et al.
Cancer Epidemiology (2013) Vol. 37, Iss. 3, pp. 219-225
Closed Access | Times Cited: 246
Use of Potentially Curative Therapies for Muscle-invasive Bladder Cancer in the United States: Results from the National Cancer Data Base
Phillip J. Gray, Stacey A. Fedewa, William U. Shipley, et al.
European Urology (2012) Vol. 63, Iss. 5, pp. 823-829
Closed Access | Times Cited: 234
Prospective Implementation of Enhanced Recovery After Surgery Protocols to Radical Cystectomy
Karl H. Pang, Ruth Groves, Suresh Venugopal, et al.
European Urology (2017) Vol. 73, Iss. 3, pp. 363-371
Open Access | Times Cited: 188
Role of neutrophil extracellular traps in radiation resistance of invasive bladder cancer
Surashri Shinde-Jadhav, José João Mansure, Roni Rayes, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 142
2025 Canadian Urological Association Expert Report: Muscle-invasive bladder cancer
Girish S. Kulkarni, Peter C. Black, Srikala S. Sridhar, et al.
Canadian Urological Association Journal (2025) Vol. 19, Iss. 1, pp. E1-16
Open Access | Times Cited: 2
When Do Firms Divest Foreign Operations?
Heather Berry
Organization Science (2012) Vol. 24, Iss. 1, pp. 246-261
Closed Access | Times Cited: 203
Impact of a structured quality management program on surgical outcome in primary advanced ovarian cancer
Philipp Harter, Z Muallem, Constanze Buhrmann, et al.
Gynecologic Oncology (2011) Vol. 121, Iss. 3, pp. 615-619
Closed Access | Times Cited: 192
Treatment of Muscle Invasive Bladder Cancer: Evidence From the National Cancer Database, 2003 to 2007
Ugo Fedeli, Stacey A. Fedewa, Elizabeth Ward
The Journal of Urology (2010) Vol. 185, Iss. 1, pp. 72-78
Closed Access | Times Cited: 186
Muscle‐invasive bladder cancer: evaluating treatment and survival in the National Cancer Data Base
Angela Smith, Allison M. Deal, Michael Woods, et al.
BJU International (2013) Vol. 114, Iss. 5, pp. 719-726
Closed Access | Times Cited: 155
Compliance with guidelines for patients with bladder cancer
Karim Chamie, Christopher S. Saigal, Julie Lai, et al.
Cancer (2011) Vol. 117, Iss. 23, pp. 5392-5401
Open Access | Times Cited: 149
Issues in the Reporting and Conduct of Instrumental Variable Studies
Neil M Davies, George Davey Smith, Frank Windmeijer, et al.
Epidemiology (2013) Vol. 24, Iss. 3, pp. 363-369
Open Access | Times Cited: 132
A Contemporary Update on Pathology Standards for Bladder Cancer: Transurethral Resection and Radical Cystectomy Specimens
Donna E. Hansel, Mahul B. Amin, Éva Compérat, et al.
European Urology (2012) Vol. 63, Iss. 2, pp. 321-332
Closed Access | Times Cited: 129
Association Between the Number of Dissected Lymph Nodes During Pelvic Lymphadenectomy and Cancer-Specific Survival in Patients with Lymph Node–Negative Urothelial Carcinoma of the Bladder Undergoing Radical Cystectomy
Matthias May, Edwin Herrmann, Christian Bolenz, et al.
Annals of Surgical Oncology (2011) Vol. 18, Iss. 7, pp. 2018-2025
Closed Access | Times Cited: 126
Methods in Comparative Effectiveness Research
Katrina Armstrong
Journal of Clinical Oncology (2012) Vol. 30, Iss. 34, pp. 4208-4214
Open Access | Times Cited: 117
Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of renal cell carcinoma
Brian I. Rini, David F. McDermott, Hans J. Hammers, et al.
Journal for ImmunoTherapy of Cancer (2016) Vol. 4, Iss. 1
Open Access | Times Cited: 117
Laparoscopic versus Open Radical Cystectomy in Bladder Cancer: A Systematic Review and Meta-Analysis of Comparative Studies
Kun Tang, Heng Li, Xia Ding, et al.
PLoS ONE (2014) Vol. 9, Iss. 5, pp. e95667-e95667
Open Access | Times Cited: 104
Long term survival with stereotactic ablative radiotherapy (SABR) versus thoracoscopic sublobar lung resection in elderly people: national population based study with propensity matched comparative analysis
Subroto Paul, Paul C. Lee, Jialin Mao, et al.
BMJ (2016), pp. i3570-i3570
Open Access | Times Cited: 94
Defining cisplatin eligibility in patients with muscle-invasive bladder cancer
Di Jiang, Shilpa Gupta, Abhijat Kitchlu, et al.
Nature Reviews Urology (2021) Vol. 18, Iss. 2, pp. 104-114
Closed Access | Times Cited: 92
Impact of Centralizing Care for Genitourinary Malignancies to High-volume Providers: A Systematic Review
Stephen B. Williams, Mohamed D. Ray-Zack, Hogan K. Hudgins, et al.
European Urology Oncology (2018) Vol. 2, Iss. 3, pp. 265-273
Open Access | Times Cited: 91
Comparing Survival Outcomes and Costs Associated With Radical Cystectomy and Trimodal Therapy for Older Adults With Muscle-Invasive Bladder Cancer
Stephen B. Williams, Yong Shan, Usama Jazzar, et al.
JAMA Surgery (2018) Vol. 153, Iss. 10, pp. 881-881
Open Access | Times Cited: 89
Bricker ileal conduit vs. Cutaneous ureterostomy after radical cystectomy for bladder cancer: a systematic review
Fernando Korkes, Eduardo S. M. Fernandes, Felipe Arakaki Gushiken, et al.
International braz j urol (2022) Vol. 48, Iss. 1, pp. 18-30
Open Access | Times Cited: 49
The Prognostic Significance of Histological Subtypes in Patients with Muscle-Invasive Bladder Cancer: An Overview of the Current Literature
Francesco Claps, Arianna Biasatti, Luca Di Gianfrancesco, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 15, pp. 4349-4349
Open Access | Times Cited: 17
Page 1 - Next Page

Scroll to top